380 related articles for article (PubMed ID: 35315695)
1. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
Wang S; Heuler J; Wickramage I; Sun X
Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
[TBL] [Abstract][Full Text] [Related]
2. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
Wang S; Zhu D; Sun X
Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
[TBL] [Abstract][Full Text] [Related]
3. Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
Wang Y; Wang S; Bouillaut L; Li C; Duan Z; Zhang K; Ju X; Tzipori S; Sonenshein AL; Sun X
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150259
[TBL] [Abstract][Full Text] [Related]
4. Strain-Dependent RstA Regulation of Clostridioides difficile Toxin Production and Sporulation.
Edwards AN; Krall EG; McBride SM
J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31659010
[TBL] [Abstract][Full Text] [Related]
5. Detection and elimination of a novel non-toxigenic
Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
[No Abstract] [Full Text] [Related]
6. An Aniline-Substituted Bile Salt Analog Protects both Mice and Hamsters from Multiple Clostridioides difficile Strains.
Phan JR; Do DM; Truong MC; Ngo C; Phan JH; Sharma SK; Schilke A; Mefferd CC; Villarama JV; Lai D; Consul A; Hedlund BP; Firestine SM; Abel-Santos E
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0143521. PubMed ID: 34780262
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the virulence of a non-RT027, non-RT078 and binary toxin-positive Clostridium difficile strain associated with severe diarrhea.
Li C; Harmanus C; Zhu D; Meng X; Wang S; Duan J; Liu S; Fu C; Zhou P; Liu R; Wu A; Kuijper EJ; Smits WK; Fu L; Sun X
Emerg Microbes Infect; 2018 Dec; 7(1):211. PubMed ID: 30542069
[TBL] [Abstract][Full Text] [Related]
8. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
9. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
10. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
[TBL] [Abstract][Full Text] [Related]
11. The microbial metabolite urolithin A reduces
Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
[No Abstract] [Full Text] [Related]
12. Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
Secore S; Wang S; Doughtry J; Xie J; Miezeiewski M; Rustandi RR; Horton M; Xoconostle R; Wang B; Lancaster C; Kristopeit A; Wang SC; Christanti S; Vitelli S; Gentile MP; Goerke A; Skinner J; Strable E; Thiriot DS; Bodmer JL; Heinrichs JH
PLoS One; 2017; 12(1):e0170640. PubMed ID: 28125650
[TBL] [Abstract][Full Text] [Related]
13. Cwl0971, a novel peptidoglycan hydrolase, plays pleiotropic roles in Clostridioides difficile R20291.
Zhu D; Patabendige HMLW; Tomlinson BR; Wang S; Hussain S; Flores D; He Y; Shaw LN; Sun X
Environ Microbiol; 2021 Sep; 23(9):5222-5238. PubMed ID: 33893759
[TBL] [Abstract][Full Text] [Related]
14. Comparative biofilm-forming ability between
Morais MLGDS; Santos MGC; Costa CL; Martins CS; Leitão RFC; de Melo Pacífico D; Quesada-Gómez C; Castelo Branco D; Ferreira EO; Brito GAC
Front Cell Infect Microbiol; 2022; 12():1033698. PubMed ID: 36619751
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis and genotyping of pathogenicity locus in Clostridioides difficile strains isolated from patients in Tehran hospitals during the years 2007-2010.
Azimirad M; Azizi O; Alebouyeh M; Aslani MM; Mousavi SF; Zali MR
Infect Genet Evol; 2019 Jul; 71():205-210. PubMed ID: 30902742
[TBL] [Abstract][Full Text] [Related]
16. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
17. Phage transcriptional regulator X (PtrX)-mediated augmentation of toxin production and virulence in Clostridioides difficile strain R20291.
Gong JJ; Huang IH; Su MS; Xie SX; Liu WY; Huang CR; Hung YP; Wu SR; Tsai PJ; Ko WC; Chen JW
Microbiol Res; 2024 Mar; 280():127576. PubMed ID: 38183754
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.
Romano MR; Leuzzi R; Cappelletti E; Tontini M; Nilo A; Proietti D; Berti F; Costantino P; Adamo R; Scarselli M
Toxins (Basel); 2014 Apr; 6(4):1385-96. PubMed ID: 24759173
[TBL] [Abstract][Full Text] [Related]
19. A local-scale One Health genomic surveillance of
Williamson CHD; Roe CC; Terriquez J; Hornstra H; Lucero S; Nunnally AE; Vazquez AJ; Vinocur J; Plude C; Nienstadt L; Stone NE; Celona KR; Wagner DM; Keim P; Sahl JW
Microb Genom; 2023 Jun; 9(6):. PubMed ID: 37347682
[TBL] [Abstract][Full Text] [Related]
20. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.
Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF
Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
